Suppr超能文献

二价金属离子转运蛋白1的小分子抑制剂

Small molecule inhibitors of divalent metal transporter-1.

作者信息

Buckett Peter D, Wessling-Resnick Marianne

机构信息

Harvard School of Public Health, Department of Genetics and Complex Diseases, 665 Huntington Ave., Boston, MA 02115, USA.

出版信息

Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G798-804. doi: 10.1152/ajpgi.90342.2008. Epub 2009 Jan 29.

Abstract

Divalent metal transporter-1 (DMT1) is a divalent cation transporter that plays a key role in iron metabolism by mediating ferrous iron uptake across the small intestine. We have previously identified several small molecule inhibitors of iron uptake (4). Using a cell line that stably overexpresses DMT1, we screened the ability of these inhibitors to specifically block this transporter's activity. One compound, NSC306711, inhibited DMT1-mediated iron uptake in a reversible and competitive manner. This inhibitor is a polysulfonated dye containing two copper centers. Although one of these two sites could be chelated by Triethylenetetramine copper chelation did not perturb NSC306711 inhibition of DMT1 activity. Several other polysulfonated dyes with structural features similar to NSC306711 were identified as potential DMT1 transport inhibitors. This study characterizes important pharmacological tools that can be used to probe DMT1's mechanism of iron transport and its role in iron metabolism.

摘要

二价金属转运蛋白1(DMT1)是一种二价阳离子转运蛋白,通过介导亚铁在小肠的吸收,在铁代谢中发挥关键作用。我们之前已鉴定出几种铁吸收的小分子抑制剂(4)。利用稳定过表达DMT1的细胞系,我们筛选了这些抑制剂特异性阻断该转运蛋白活性的能力。一种化合物NSC306711以可逆且竞争性的方式抑制DMT1介导的铁吸收。该抑制剂是一种含有两个铜中心的多磺酸化染料。虽然这两个位点之一可被三亚乙基四胺螯合,但铜螯合并不干扰NSC306711对DMT1活性的抑制。其他几种具有与NSC306711相似结构特征的多磺酸化染料被鉴定为潜在的DMT1转运抑制剂。本研究表征了可用于探究DMT1铁转运机制及其在铁代谢中作用的重要药理学工具。

相似文献

1
Small molecule inhibitors of divalent metal transporter-1.
Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G798-804. doi: 10.1152/ajpgi.90342.2008. Epub 2009 Jan 29.
3
Mathematical modeling of the relocation of the divalent metal transporter DMT1 in the intestinal iron absorption process.
PLoS One. 2019 Jun 10;14(6):e0218123. doi: 10.1371/journal.pone.0218123. eCollection 2019.
5
Divalent metal transporter 1.
Hematology. 2005 Aug;10(4):339-45. doi: 10.1080/10245330500093419.
6
Discovery of benzylisothioureas as potent divalent metal transporter 1 (DMT1) inhibitors.
Bioorg Med Chem Lett. 2012 Aug 1;22(15):5108-13. doi: 10.1016/j.bmcl.2012.05.129. Epub 2012 Jun 15.
7
A role for divalent metal transporter (DMT1) in mitochondrial uptake of iron and manganese.
Sci Rep. 2018 Jan 9;8(1):211. doi: 10.1038/s41598-017-18584-4.
8
Chaperone protein involved in transmembrane transport of iron.
Biochem J. 2014 Aug 15;462(1):25-37. doi: 10.1042/BJ20140225.
9
Interaction of calcium with the human divalent metal-ion transporter-1.
Biochem Biophys Res Commun. 2010 Mar 12;393(3):471-5. doi: 10.1016/j.bbrc.2010.02.025. Epub 2010 Feb 10.
10
Regulation of divalent metal transporter-1 by serine phosphorylation.
Biochem J. 2016 Nov 15;473(22):4243-4254. doi: 10.1042/BCJ20160674. Epub 2016 Sep 28.

引用本文的文献

1
In vivo silencing of intestinal DMT1 mitigates iron loading in β-thalassemia intermedia (Hbbth3/+) mice.
Blood Adv. 2024 Nov 26;8(22):5753-5765. doi: 10.1182/bloodadvances.2024013333.
2
Managing Iron Overload: A Gut Check.
J Pharmacol Exp Ther. 2023 Jul;386(1):1-3. doi: 10.1124/jpet.123.001645.
5
The Divalent Metal Transporter 1 (DMT1) Is Required for Iron Uptake and Normal Development of Oligodendrocyte Progenitor Cells.
J Neurosci. 2018 Oct 24;38(43):9142-9159. doi: 10.1523/JNEUROSCI.1447-18.2018. Epub 2018 Sep 6.
6
Zinc ions have a potential to attenuate both Ni ion uptake and Ni ion-induced inflammation.
Sci Rep. 2018 Feb 13;8(1):2911. doi: 10.1038/s41598-018-21014-8.
7
Targeting iron metabolism in drug discovery and delivery.
Nat Rev Drug Discov. 2017 Jun;16(6):400-423. doi: 10.1038/nrd.2016.248. Epub 2017 Feb 3.
8
Regulation of divalent metal transporter-1 by serine phosphorylation.
Biochem J. 2016 Nov 15;473(22):4243-4254. doi: 10.1042/BCJ20160674. Epub 2016 Sep 28.
9
The small molecule ferristatin II induces hepatic hepcidin expression in vivo and in vitro.
Am J Physiol Gastrointest Liver Physiol. 2015 Jun 15;308(12):G1019-26. doi: 10.1152/ajpgi.00324.2014. Epub 2015 Apr 23.
10
Ebselen, a promising antioxidant drug: mechanisms of action and targets of biological pathways.
Mol Biol Rep. 2014 Aug;41(8):4865-79. doi: 10.1007/s11033-014-3417-x.

本文引用的文献

2
Haemochromatosis.
Lancet. 2007 Dec 1;370(9602):1855-60. doi: 10.1016/S0140-6736(07)61782-6.
3
Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1.
Nat Med. 2007 Apr;13(4):448-54. doi: 10.1038/nm1542. Epub 2007 Feb 11.
6
DMT1: which metals does it transport?
Biol Res. 2006;39(1):79-85. doi: 10.4067/s0716-97602006000100009.
8
Iron and transition metal transport into erythrocytes mediated by nifedipine degradation products and related compounds.
Biochem Pharmacol. 2003 Apr 15;65(8):1215-26. doi: 10.1016/s0006-2952(03)00045-5.
9
HFE and non-HFE hemochromatosis.
Int J Hematol. 2002 Oct;76(3):203-7. doi: 10.1007/BF02982788.
10
Secondary iron overload.
Hematology Am Soc Hematol Educ Program. 2001:47-61. doi: 10.1182/asheducation-2001.1.47.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验